NCT07725042Recruiting
Analyses of Newly Diagnosed HIV Infection in Hong Kong
Combined Epidemiologic and Molecular Network Analyses of Newly Diagnosed HIV Infection in Hong Kong
Source: ClinicalTrials.gov · Last updated 24 Jul 2026
Brief summary (registry, in English)
The goal of the project is to determine the epidemiologic status and changing patterns of HIV infection in Hong Kong. The main question it aims to answer is: \- what is the molecular pattern and burden of HIV-1 infections over the years
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 720 (estimated)
- First submitted
- 21 Jul 2026
- Start date
- 1 Aug 2024
- Primary completion date
- Jul 2029
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- HIV
- NCT number
- NCT07725042
What you commit to
- Study type: Observational
- Planned participants: 720
- From 1 Aug 2024 to the primary completion date, Jul 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients with mental illnesses who are unable to make informed decision
- patients whose HIV diagnosis was made outside Hong Kong and whose treatment have already started.
Other
- travelers or visitors who are temporarily staying in Hong Kong
- prisoners
Who the study is looking for
- adult of age 18 or above, who are
- people living with HIV, and
- attending the service of an HIV specialist clinic in the public service in Hong Kong
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| S.H. Ho Research Centre for Infectious Diseases Coordinator of this site? Confirm its status | North Point | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.